NIB continues financing hearing healthcare R&D
The Nordic Investment Bank (NIB) and the Danish global hearing healthcare company Demant A/S agree to a new 7-year loan agreement of DKK 375 million (EUR 49.2 million) to finance the company’s advancement in hearing solutions and technology research and development.NIB’s loan will co-finance Demant’s research and development programme for the 2021-2022 period. Demant’s R&D focus on hearing healthcare and audio technology. Demant has an extensive and comprehensive R&D programme, partnering with different universities, research centers and companies primarily in Denmark. The Bank has provided